Amir Nashat, Director, 10% Owner at Camp4 Therapeutics Corp (CAMP), bought 2,614,378 shares at $1.53 ($4.0M) on 2025-09-11, disclosed to the SEC on 2025-09-11.
Open-market purchase of $4.0M CAMP by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.53 | 85,468 | $131K | 3.3% |
| 2 | $1.53 | 85,468 | $131K | 3.3% |
| 3 | $1.53 | 1,221,721 | $1.9M | 46.7% |
| 4 | $1.53 | 1,221,721 | $1.9M | 46.7% |
| Total | $1.53 avg | 2,614,378 | $4.0M | 100% |
| Filing → |
| MORF | SELL | 2021-05-25 | $20.4M | — | Filing → |
| MTCR | BUY | 2020-09-22 | $3.0M | — | Filing → |
| FATE | SELL | 2019-08-02 | $2.8M | — | Filing → |